Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up

Objective: to study the efficiency and safety of tocilizumab (TCZ) therapy in patients with systemic-onset juvenile idiopathic arthritis (sJIA). Patients and methods. The retrospective study included 48 children with active sJIA in whom TCZ therapy was initiated because of the inefficiency of using...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	M. M. Kostik, E. A. Isupova, I. A. Chikova, M. F. Dubko, V. V. Masalova, L. S. Snegireva, O. V. Kalashnikova, V. G. Chasnyk
Fformat:	Artigo
Iaith:	Russo
Cyhoeddwyd:	IMA-PRESS LLC 2018-01-01
Cyfres:	Современная ревматология
Pynciau:	systemic juvenile idiopathic arthritis interleukin-6 tocilizumab remission
Mynediad Ar-lein:	https://mrj.ima-press.net/mrj/article/view/793
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!